Q Strategy Group

My work is rooted in advanced clinical experience within trauma-informed psychotherapy, ketamine-assisted psychotherapy, and emerging psychedelic care models. As Director of Ketamine-Assisted Psychotherapy programming within a multi-site innovative psychiatric practice, I helped develop and operationalize therapeutic frameworks designed to support psychological safety, preparation, integration, and meaningful long-term transformation within psychedelic treatment settings. In addition to direct clinical care, my experience has lead me to lead therapist/LSM positions in clinical trials testing psilocybin compounds with Compass Pathways and Helus Pharma. My work has extended beyond the therapy room into program development, therapist education, protocol development, operationalization, local/global psychedelic advocacy, and laying down of psychedelic infrastructure here in Chicago. What continues to guide my approach most deeply, however, is the belief that transformative work requires more than insight alone — it requires safety, trust, and connection. I create a grounded, compassionate therapeutic space where individuals feel emotionally supported, deeply understood, and safe.